Free Trial

Enlivex Therapeutics (ENLV) SEC Filings & 10K Form

Enlivex Therapeutics logo
$0.96 +0.01 (+0.52%)
As of 01:44 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Enlivex Therapeutics SEC Filings

DateFilerForm TypeView
04/23/2025
7:32 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/21/2025
7:32 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/03/2025
7:02 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/17/2025
7:02 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/03/2025
7:23 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
5:22 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2025
4:43 PM
ARMISTICE CAPITAL, LLC (Filed by)
Enlivex Therapeutics Ltd. (Subject)
Enlivex Therapeutics (Subject)
Form SCHEDULE 13G/A
12/11/2024
7:33 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/03/2024
7:32 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/29/2024
3:30 PM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2024
7:02 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
7:01 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2024
3:05 PM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/30/2024
7:01 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
5:03 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K/A
09/26/2024
7:32 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/24/2024
7:33 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/11/2024
7:30 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/23/2024
7:02 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2024
7:02 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2024
7:04 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2024
7:03 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/14/2024
3:30 PM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2024
7:05 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
7:13 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
7:01 AM
Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ENLV) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners